EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clearance of Strongyloides stercoralis infection using ivermectin improves kidney function and modulates untargeted urinary metabolomic profile in patients with early-stage chronic kidney disease

Keerapach Tunbenjasiri, Suppakrit Kongsintaweesuk, Kornpatchara Chaiyachate, Aye Myat Mon, Thatsanapong Pongking, Apinya Jusakul iD, Sirirat Anutrakulchai, Apisit Chaidee iD, Porntip Pinlaor, Nuttanan Hongsrichan, Ubon Cha'on, David Blair und 1 weitere

PeerJ · 29.10.2026 · 14 · e21832

DOI: 10.7717/peerj.21832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 29.10.2026. Verfasst von Keerapach Tunbenjasiri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Strongyloidiasis, Strongyloides stercoralis, Ivermectin, Renal Insufficiency, Chronic. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khon Kaen University, Thailand, The National Science Research and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Strongyloides stercoralis exacerbates the early stages of chronic kidney disease (CKD) through the disruption of metabolic processes. However, the metabolic consequences of infection and of its resolution after treatment remain poorly characterized. This study explores urinary metabolic changes in patients with early-stage CKD following antiparasitic therapy.

Methods

In an exploratory before-and-after longitudinal study design, fifteen patients presenting with concurrent early-stage CKD (stages 1–3) and confirmed strongyloidiasis were monitored at baseline and 17 months following ivermectin anthelmintic treatment. Serum and urine clinical biochemistry assessments were paired with high-resolution untargeted liquid chromatography-quadrupole time-of-flight mass spectrometry (LC/Q-TOF MS) urinary metabolomic profiling executed in both negative and positive ionization modes.

Results

Global multivariate analyses did not demonstrate statistically significant separation between pre- and post-treatment urinary metabolomic profiles. However, univariate analyses identified 91 significantly altered urinary mass features following treatment. Among these, thirteen metabolites (twelve decreased and one increased) were identified as potential markers associated with parasite clearance in patients with CKD. Changes in fasting blood sugar, serum creatinine, and estimated glomerular filtration rate (eGFR) were also observed. Notably, urinary 1-O-galloyl-6-O-cinnamoylglucose was negatively correlated with urine creatinine, while sedoheptulose-7-phosphate levels was negatively correlated with serum creatinine. Additionally, urinary ascorbic acid levels increased following treatment, suggesting their potential relevance to kidney function. Pathway analysis indicated disturbances in amino acid and carbohydrate metabolism, particularly glycine/serine metabolism, tyrosine metabolism, and glycolysis, that partially normalized post-treatment.

Conclusion

These findings suggest that clearance of S. stercoralis infection was associated with changes in urinary metabolomic profiles in patients with CKD. Kidney function and urinary metabolomic profiles were observed in patients with early-stage CKD and S. stercoralis infection. Further investigations of kidney outcomes following S. stercoralis clearance and of the potential value of strongyloidiasis screening in patients with CKD are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrongyloidiasisStrongyloides stercoralisIvermectinRenal Insufficiency, ChronicMetabolomeAnthelminticsHumansAnimalsFemaleMaleMiddle AgedLongitudinal StudiesMetabolomicsAgedAdultBiomarkersKidney

Stichwörter der Autor:innen

Early stageHelminth treatmentKidney diseaseMetabolic profilingStrongyloidiasis

Substanzen

IvermectinAnthelminticsBiomarkers

Autor:innen und Institutionen

  • Biomedical Sciences Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand.
  • Chronic Kidney Disease Prevention in Northeastern Thailand, Khon Kaen University, Khon Kaen, Thailand.
  • Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

ORCID-Profile: Apinya Jusakul, Apisit Chaidee

Förderung

  • Khon Kaen University, Thailand
  • The National Science Research and Innovation Fund

Zitieren

APA

Tunbenjasiri, K., Kongsintaweesuk, S., Chaiyachate, K., Mon, A. M., Pongking, T., Jusakul, A., Anutrakulchai, S., Chaidee, A., Pinlaor, P., Hongsrichan, N., Cha'on, U., Blair, D., & Pinlaor, S. (2026). Clearance of Strongyloides stercoralis infection using ivermectin improves kidney function and modulates untargeted urinary metabolomic profile in patients with early-stage chronic kidney disease. PeerJ, 14, e21832. https://doi.org/10.7717/peerj.21832

Vancouver

Tunbenjasiri K, Kongsintaweesuk S, Chaiyachate K, Mon AM, Pongking T, Jusakul A, et al. Clearance of Strongyloides stercoralis infection using ivermectin improves kidney function and modulates untargeted urinary metabolomic profile in patients with early-stage chronic kidney disease. PeerJ. 2026;14:e21832. doi:10.7717/peerj.21832

BibTeX
@article{Tunbenjasiri2026,
  author = {Tunbenjasiri, Keerapach and Kongsintaweesuk, Suppakrit and Chaiyachate, Kornpatchara and Mon, Aye Myat and Pongking, Thatsanapong and Jusakul, Apinya and Anutrakulchai, Sirirat and Chaidee, Apisit and Pinlaor, Porntip and Hongsrichan, Nuttanan and Cha'on, Ubon and Blair, David and Pinlaor, Somchai},
  title = {Clearance of Strongyloides stercoralis infection using ivermectin improves kidney function and modulates untargeted urinary metabolomic profile in patients with early-stage chronic kidney disease},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21832},
  doi = {10.7717/peerj.21832}
}
Kostenlos starten →